Literature DB >> 11222989

Role of CRF receptor 1 in central CRF-induced stimulation of colonic propulsion in rats.

V Martínez1, Y Taché.   

Abstract

The CRF receptor subtype mediating the colonic and gastric motor responses to central CRF was investigated in conscious rats. CRF (0.6 microg/rat) injected intracerebroventicularly (i.c.v.) or 1 h water avoidance stress stimulated defecation (pellet/60 min: 4.1+/-1.0 and 8.7+/-0.7 respectively vs. 0.3+/-0.3 in i.c.v. vehicle/no stress). The CRF receptor 1 (CRF-R1) antagonist, NBI-27914 (50-100 microg/rat) injected i.c.v., abolished the colonic response to i.c.v. CRF and dose-dependently reduced that induced by water avoidance stress. NBI-27914 (100 microg/rat) injected peripherally did not influence the defecatory response to stress. The peptide CRF-R1/R2 antagonist, astressin (10 microg/rat, i.c.v.) inhibited the colonic motor response to i.c.v. CRF and stress similarly as NBI-27914 injected i.c.v. at 100 microg/rat. Intracisternal (i.c.) injection of astressin (10 microg/rat) also completely prevented CRF (0.6 g, i.c.)-induced delayed gastric emptying while i.c. NBI-27914 (50 or 100 microg) had no effect. These results indicate a differential role of central CRF receptor subtypes in the colonic stimulatory and gastric inhibitory motor responses to central CRF and that the CRF component of stress-related activation of colonic expulsion is primarily mediated by CRF-R1.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11222989     DOI: 10.1016/s0006-8993(00)03277-7

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  29 in total

1.  Urocortin III-immunoreactive projections in rat brain: partial overlap with sites of type 2 corticotrophin-releasing factor receptor expression.

Authors:  Chien Li; Joan Vaughan; Paul E Sawchenko; Wylie W Vale
Journal:  J Neurosci       Date:  2002-02-01       Impact factor: 6.167

Review 2.  Role of thyrotrophin releasing hormone and corticotrophin releasing factor in stress related alterations of gastrointestinal motor function.

Authors:  C Beglinger; L Degen
Journal:  Gut       Date:  2002-07       Impact factor: 23.059

Review 3.  Treating irritable bowel syndrome: overview, perspective and future therapies.

Authors:  Michael Camilleri
Journal:  Br J Pharmacol       Date:  2004-03-22       Impact factor: 8.739

Review 4.  Corticotropin-releasing factor receptors and stress-related alterations of gut motor function.

Authors:  Yvette Taché; Bruno Bonaz
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

5.  Role of nesfatin-1 in a rat model of visceral hypersensitivity.

Authors:  Fang-Yuan Jia; Xue-Liang Li; Tian-Nv Li; Jing Wu; Bi-Yun Xie; Lin Lin
Journal:  World J Gastroenterol       Date:  2013-06-14       Impact factor: 5.742

6.  Effects of psychological stress on small intestinal motility and expression of cholecystokinin and vasoactive intestinal polypeptide in plasma and small intestine in mice.

Authors:  Shu-Guang Cao; Wan-Chun Wu; Zhen Han; Meng-Ya Wang
Journal:  World J Gastroenterol       Date:  2005-02-07       Impact factor: 5.742

7.  Endogenous CRF in rat large intestine mediates motor and secretory responses to stress.

Authors:  S Liu; J Chang; N Long; K Beckwith; G Talhouarne; J J Brooks; M-H Qu; W Ren; J D Wood; S Cooper; A Bhargava
Journal:  Neurogastroenterol Motil       Date:  2015-11-26       Impact factor: 3.598

Review 8.  CRF1 receptor signaling pathways are involved in stress-related alterations of colonic function and viscerosensitivity: implications for irritable bowel syndrome.

Authors:  Y Taché; V Martinez; L Wang; M Million
Journal:  Br J Pharmacol       Date:  2004-04       Impact factor: 8.739

9.  Urocortin prevents indomethacin-induced small intestinal lesions in rats through activation of CRF2 receptors.

Authors:  Yoshikazu Kubo; Aiko Kumano; Kohei Kamei; Kikuko Amagase; Naoko Abe; Koji Takeuchi
Journal:  Dig Dis Sci       Date:  2009-08-26       Impact factor: 3.199

Review 10.  Modulation of the adaptive response to stress by brain activation of selective somatostatin receptor subtypes.

Authors:  Andreas Stengel; Jean Rivier; Yvette Taché
Journal:  Peptides       Date:  2012-12-31       Impact factor: 3.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.